These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32508253)

  • 1. Exposure to natalizumab during pregnancy and lactation is safe - Yes.
    Landi D; Marfia GA
    Mult Scler; 2020 Jul; 26(8):887-889. PubMed ID: 32508253
    [No Abstract]   [Full Text] [Related]  

  • 2. Exposure to natalizumab during pregnancy and lactation is safe - No.
    Airas L
    Mult Scler; 2020 Jul; 26(8):889-891. PubMed ID: 32508200
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder.
    Ciplea AI; Langer-Gould A; de Vries A; Schaap T; Thiel S; Ringelstein M; Gold R; Hellwig K
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32327455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natalizumab exposure during pregnancy in multiple sclerosis: a systematic review.
    Peng A; Qiu X; Zhang L; Zhu X; He S; Lai W; Chen L
    J Neurol Sci; 2019 Jan; 396():202-205. PubMed ID: 30502611
    [No Abstract]   [Full Text] [Related]  

  • 5. Natalizumab during pregnancy and lactation.
    Proschmann U; Thomas K; Thiel S; Hellwig K; Ziemssen T
    Mult Scler; 2018 Oct; 24(12):1627-1634. PubMed ID: 28857686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How safe is natalizumab during pregnancy?
    Duquette P; Prat A
    Mult Scler; 2015 Feb; 21(2):121-2. PubMed ID: 25392323
    [No Abstract]   [Full Text] [Related]  

  • 7. [Disease modifying drugs in multiple sclerosis and pregnancy].
    Tur C; Tintoré M; Aguilera C
    Med Clin (Barc); 2012 Sep; 139(7):316-8. PubMed ID: 22743277
    [No Abstract]   [Full Text] [Related]  

  • 8. Pregnancy outcomes amongst multiple sclerosis females with third trimester natalizumab use.
    Triplett JD; Vijayan S; Rajanayagam S; Tuch P; Kermode AG
    Mult Scler Relat Disord; 2020 May; 40():101961. PubMed ID: 32028118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.
    Portaccio E; Moiola L; Martinelli V; Annovazzi P; Ghezzi A; Zaffaroni M; Lanzillo R; Brescia Morra V; Rinaldi F; Gallo P; Tortorella C; Paolicelli D; Pozzilli C; De Giglio L; Cavalla P; Cocco E; Marrosu MG; Solaro C; Uccelli A; Laroni A; Pastò L; Giannini M; Trojano M; Comi G; Amato MP;
    Neurology; 2018 Mar; 90(10):e832-e839. PubMed ID: 29438041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of healthy babies after natalizumab use for multiple sclerosis: a report of two cases.
    Hoevenaren IA; de Vries LC; Rijnders RJ; Lotgering FK
    Acta Neurol Scand; 2011 Jun; 123(6):430-3. PubMed ID: 21492099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with natalizumab during pregnancy in multiple sclerosis: The experience of implementing a clinical practice protocol (NAP-30).
    Valero-López G; Millán-Pascual J; Iniesta-Martínez F; Delgado-Marín JL; Jimenez-Veiga J; Tejero-Martín AB; León-Hernández A; Zamarro-Parra J; Morales-Ortiz A; Meca-Lallana JE
    Mult Scler Relat Disord; 2022 Oct; 66():104038. PubMed ID: 35870370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natalizumab: retinal necrosis.
    Prescrire Int; 2017 May; 26(182):124. PubMed ID: 30730671
    [No Abstract]   [Full Text] [Related]  

  • 13. Myocardial infarction in a patient with multiple sclerosis after receiving natalizumab.
    Darki A; Masoumi P; Soleimani A; Naser Moghadasi A
    Mult Scler Relat Disord; 2018 Oct; 25():26-28. PubMed ID: 30025371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal pancytopenia in a child, born after maternal exposure to natalizumab throughout pregnancy.
    Guilloton L; Pegat A; Defrance J; Quesnel L; Barral G; Drouet A
    J Gynecol Obstet Hum Reprod; 2017 Mar; 46(3):301-302. PubMed ID: 28403930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug and Neurofilament Levels in Serum and Breastmilk of Women With Multiple Sclerosis Exposed to Natalizumab During Pregnancy and Lactation.
    Proschmann U; Haase R; Inojosa H; Akgün K; Ziemssen T
    Front Immunol; 2021; 12():715195. PubMed ID: 34512637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PML in natalizumab-treated multiple sclerosis: Modeling errors and risk miscalculations.
    Mowry EM; McArthur JC
    Neurology; 2017 Mar; 88(12):1110-1111. PubMed ID: 28228562
    [No Abstract]   [Full Text] [Related]  

  • 17. High-frequency MRI monitoring should be performed in natalizumab-treated MS patients with higher risk of PML - NO.
    Enzinger C
    Mult Scler; 2017 May; 23(6):767-770. PubMed ID: 28287038
    [No Abstract]   [Full Text] [Related]  

  • 18. Progressive outer retinal necrosis in a multiple sclerosis patient on natalizumab.
    Bourre B; Gueudry J; Lefaucheur R; Borden A; Maltête D; Patel SS; Van Tassel SH; Gupta MP; Orlin A; Nealon NM
    Neurology; 2016 Jan; 86(3):312-3. PubMed ID: 26783270
    [No Abstract]   [Full Text] [Related]  

  • 19. Transfer of natalizumab into breast milk in a mother with multiple sclerosis.
    Baker TE; Cooper SD; Kessler L; Hale TW
    J Hum Lact; 2015 May; 31(2):233-6. PubMed ID: 25586712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natalizumab concentrations during pregnancy in three patients with multiple sclerosis: A clinical commentary.
    Dobson R; Chung K
    Mult Scler; 2022 Feb; 28(2):326-327. PubMed ID: 35083940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.